Angiodynamics (ANGO) Net Cash Flow Growth (1y) (2011 - 2026)
Angiodynamics (ANGO) Net Cash Flow Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | - |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | -9.88% |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 131.47% |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | -47.85% |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | -40.20% |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | -196.55% |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 102.38% |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | -41.07% |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 84.02% |
| 10 | Angiodynamics | 558.11 Mn | 504.25 Mn | 46.77 Mn | 54.29% |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 54.29% |
| Feb 28, 2026 | 56.57% |
| Nov 30, 2025 | 582.49% |
| Aug 31, 2025 | 18.17% |
| May 31, 2025 | 546.17% |
| Feb 28, 2025 | -152.36% |
| Nov 30, 2024 | -119.58% |
| Aug 31, 2024 | -263.41% |
| May 31, 2024 | -116.19% |
| Feb 29, 2024 | 10,549.70% |
| Nov 30, 2023 | -38.88% |
| Aug 31, 2023 | 428.34% |
| May 31, 2023 | 181.98% |
| Feb 28, 2023 | 101.58% |
| Nov 30, 2022 | 628.57% |
| Aug 31, 2022 | 68.57% |
| May 31, 2022 | 180.06% |
| Feb 28, 2022 | -194.88% |
| Nov 30, 2021 | -109.59% |
| Aug 31, 2021 | -85.71% |